EP2061485
EV576 peptides for use in the treatment of Guillain Barré syndrome
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.9.2007EP published:
22.8.2012EP application number:
07804199.3
EPO information:
European Patent Register
Max expiry date:
9.9.2027
Title:
EV576 peptides for use in the treatment of Guillain Barré syndrome
Timeline
Today
10.9.2007EP application
22.8.2012EP Publication
Owner
Name:
Varleigh Immuno Pharmaceuticals (VIP) LtdAddress:
Landmark Fiduciaire (Suisse) SA 6 Place des Eaux-Vives Case Postale 3461, 1211 Geneva 3, CH
Inventor
Name:
HAMER, JohnAddress:
London W1T 4EU, GB
Priority
Number:
0617734Date:
8.9.2006Country:
GB
Classification
Categories:
A61K 38/17, A61P 25/02, A61K 38/00